Literature DB >> 8088724

p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance.

J F Fléjou1, F Paraf, F Potet, F Muzeau, F Fékété, D Hénin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8088724     DOI： 10.1111/j.1365-2559.1994.tb00561.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  11 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

3.  Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Authors:  A P Ireland; D K Shibata; P Chandrasoma; R V Lord; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 4.  Barrett's esophagus. The significance of p53 in clinical practice.

Authors:  A P Ireland; G W Clark; T R DeMeester
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

5.  Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein.

Authors:  P A Hall; A C Woodman; S J Campbell; N A Shepherd
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 6.  Barrett's esophagus: model of neoplastic progression.

Authors:  Stig Ramel
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

7.  Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.

Authors:  M H Kulke; R D Odze; K S Thakore; G Thomas; H Wang; M Loda; C Eng
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

Review 8.  Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.

Authors:  L H McCormick Matthews; F Noble; J Tod; E Jaynes; S Harris; J N Primrose; C Ottensmeier; G J Thomas; T J Underwood
Journal:  Br J Cancer       Date:  2015-06-25       Impact factor: 7.640

9.  Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.

Authors:  Fiebo J C Ten Kate; Lucia Suzuki; Lambert C J Dorssers; Winand N M Dinjens; David T W Jones; Daan Nieboer; Michael Doukas; J Jan B Van Lanschot; Bas P L Wijnhoven; Leendert H J Looijenga; Katharina Biermann
Journal:  Oncotarget       Date:  2017-10-24

10.  Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.

Authors:  Lianghai Wang; Xiaodan Yu; Jing Li; Zhiyu Zhang; Jun Hou; Feng Li
Journal:  BMC Cancer       Date:  2016-07-01       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.